Cactus Life Sciences Top 5 Trends of 2024

Cactus Life Sciences’ Top 5 Trends of 2024: Insights Driving Tomorrow’s MedComms

Here, we revisit our most thought-provoking articles and whitepapers, each addressing pivotal trends that influence the ever-evolving biopharma landscape...
Read More

Top Stories

The Paradigm Shift from Traditional Scientific

In the rapidly evolving biopharma landscape, the approach to...
Involve Medical Affairs in insight management, early phases of clinical trials, etc.

It’s Never Too Soon: How and When to

Engagement with Medical Affairs is critical at every...
Leverage Social Media to Transform Medical Affairs | Promoting Disease Awareness, Ensuring Compliance and Assessing Outcomes

Leveraging Social Media to Transform Medical

This whitepaper explores the role of social media in...
Vaccine

Role of Scientific Communication and Medical Professionals in Combating Vaccine Hesitancy

Read an insightful discussion from the latest ISMPP conference on how science communication and medical...
Pexels Anna Shvets

How Academic Societies Are Embracing the New Digital World: A Look at the Years Gone by and Ahead

The pandemic has required traditional academic societies to rapidly pivot to digital formats for conferences...
Preprints, medRxiv, and pharma

Preprints, MedRxiv, and Pharma – An Overview

Non-peer reviewed and unpublished manuscripts, aka preprints, are slowly being embraced by the pharma industry...
Digital therapeutics and medical communications

Digital Therapeutics and Medical Communications: Are We Ready?

Digital Therapeutics are very new and complex, and their use will involve changing standard therapeutic...
Laptop with stethoscope

Knowledge Exchange in a New Virtual World: How the Pandemic Redefined MSL-HCP Interactions

The pandemic threw a curve ball at MSL-HCP relationships, which have traditionally relied on face-to-face...
The battle for evidence-based truth in a war of misinformation

The Battle for Evidence-Based Truth in a War of Misinformation

I was talking to someone I know — let’s call her Joanna — about the...

Learn more ABOUT our company.